Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Neurana Announces Top-Line Results from Tolperisone Phase 1 CNS Effects Study

americanpharmaceuticalreviewDecember 30, 2020

Tag: Neurana , Tolperisone , CNS

PharmaSources Customer Service